Clarity Pharmaceuticals Ltd (CU6.AX)
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States.
2.37+0.13%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-46.9%
The outlook
Clarity Pharmaceuticals Ltd currently reads as leaning bullish based on strong buy — 1.0 avg of 4 analysts, mixed vs its moving averages, 14% of the way from its 52-week low to high, avg target +205% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 4 analysts
Price trendMixed vs its moving averages
52-week range14% of the way from its 52-week low to high
Price targetAvg target +205% vs current price
Analyst price target
~12-month · 4 analysts7.23average target+205.0% vs now
Now 2.37
Low 5.60High 8.41
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$884.2M
52-wk high
5.87
52-wk low
1.80
50-day avg
2.28
200-day avg
3.12
Trailing P/E
—